Transplantation of Autologously Derived Mitochondria Following Ischemia

Description

The investigators propose a robust therapeutic intervention to ameliorate myocardial ischemia/ reperfusion injury and significantly decrease morbidity and mortality in patients requiring extracorporeal membrane oxygenation (ECMO), by direct injection of autogeneic mitochondria into the ischemic myocardium.

Study Start Date

July, 01 2016

Estimated Completion Date

July 2019

Interventions

  • Other: autologous mitochondria transplantation

Study ID

Boston Children’s Hospital -- IRB-P00014558

Status

Unknown

Trial ID

NCT02851758

Study Type

Interventional

Trial Phase

N/A

Enrollment Quota

6

Sponsor

Boston Children’s Hospital

Inclusion Criteria

  • Pediatric cardiology patients under the age of 18 on ECMO
  • concerns for ischemic injury on the Cardiac Intensive Care Unit

Exclusion Criteria

  • Known mitochondria disorders

Gender

All

Ages

17 Years and younger

Accepts Healthy Volunteers

No

Study Locations and Contact Information (5)

Study Location Distance Name Phone Email
Boston Childrens Hospital - Boston, Massachusetts 2.6 miles Breanna Piekarski RN BSN 617-919-4457 breanna.piekarski@cardio.chboston.org
Boston Childrens Hospital - Boston, Massachusetts 2.6 miles Breanna Piekarski RN BSN 617-919-4457 breanna.piekarski@cardio.chboston.org
Boston Childrens Hospital - Boston, Massachusetts 2.6 miles Breanna Piekarski RN BSN 617-919-4457 breanna.piekarski@cardio.chboston.org
Boston Childrens Hospital - Boston, Massachusetts 2.6 miles Breanna Piekarski RN BSN 617-919-4457 breanna.piekarski@cardio.chboston.org
Boston Childrens Hospital - Boston, Massachusetts 2.6 miles Breanna Piekarski RN BSN 617-919-4457 breanna.piekarski@cardio.chboston.org

ClinicalTrialsLocator.com provides clinical trial listings in an easy to view format. All clinical trial information is pulled directly from ClinicalTrials.gov. This website does not guarantee acceptance into any clinical trial, and is not responsible for adverse events that may be incurred from a clinical trial.